Myriad Genetics, Inc. (MYGN)

Last Closing Price: 5.53 (2026-11-18)

Tangible Shareholders Equity (Quarterly)

Tangible Shareholders Equity: The value shareholders equity less intangible assets.

Myriad Genetics, Inc. (MYGN) had Tangible Shareholders Equity of $90.10M for the most recently reported fiscal quarter, ending 2026-09-30.

Figures for fiscal quarter ending 2026-09-30
Income Statement Financials
$202.70M
$-43.90M
$65.00M
$137.70M
$242.60M
$-39.90M
$-3.70M
$-43.60M
$-43.60M
$-43.90M
$-43.90M
$-43.90M
$-43.90M
$-39.90M
$-27.30M
95.70M
95.70M
$-0.46
$-0.46
Balance Sheet Financials
$271.90M
$104.70M
$337.30M
$609.20M
$137.60M
$121.10M
$202.60M
$340.20M
$269.00M
Tangible Shareholders Equity
$90.10M
$269.00M
95.70M
Cash Flow Statement Financials
$-30.50M
$-11.80M
$-1.10M
$151.30M
$107.80M
$-43.50M
$22.90M
--
--
Fundamental Metrics & Ratios
1.98
--
--
0.31
0.45
67.93%
-19.68%
-19.68%
--
-21.51%
-21.66%
$-39.80M
--
--
--
0.33
2.27
1.92
46.84
-16.32%
-48.72%
-7.21%
-11.25%
$2.81
$-0.42
$-0.32